01 4Merck Canada Inc.
01 42081970
01 4Indinavir Sulfate
01 4Capsule
01 42012-11-02
Patent Expiration Date : 2012-11-02
Date Granted : 1997-07-08
Brand Name : CRIXIVAN
Patent Number : 2081970
Filing Date : 1992-11-02
Strength per Unit : 100mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-11-02
Date Granted : 1997-07-08
Patent Expiration Date : 2012-11-02
Date Granted : 1997-07-08
Brand Name : CRIXIVAN
Patent Number : 2081970
Filing Date : 1992-11-02
Strength per Unit : 200mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-11-02
Date Granted : 1997-07-08
Patent Expiration Date : 2012-11-02
Date Granted : 1997-07-08
Brand Name : CRIXIVAN
Patent Number : 2081970
Filing Date : 1992-11-02
Strength per Unit : 300mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-11-02
Date Granted : 1997-07-08
Patent Expiration Date : 2012-11-02
Date Granted : 1997-07-08
Brand Name : CRIXIVAN
Patent Number : 2081970
Filing Date : 1992-11-02
Strength per Unit : 400mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-11-02
Date Granted : 1997-07-08
